Status:
COMPLETED
Cohort Study of Chronic Heart Failure
Lead Sponsor:
Xiang Xie
Conditions:
Analyze Etiology, Comorbidities, Clinical Characteristics
Eligibility:
All Genders
19-99 years
Brief Summary
The purpose is to understand the clinical characteristics of chronic heart failure as soon as possible, analyze the etiology, comorbidities, clinical characteristics, and treatment of heart failure pa...
Detailed Description
Inclusion criteria: 1. Accompanied by difficulty breathing, fatigue, or decreased activity tolerance; 2. Signs of fluid retention (pulmonary congestion and peripheral edema); 3. Echocardiography show...
Eligibility Criteria
Inclusion
- Accompanied by difficulty breathing, fatigue, or decreased activity tolerance;
- Signs of fluid retention (pulmonary congestion and peripheral edema);
- Echocardiography shows abnormalities in cardiac structure and/or function;
- Elevated levels of natriuretic peptide: B-type natriuretic peptide (BNP)\>35 ng/L and/or N-terminal B-type proBNP (NT proBNP)\>125 ng/L.
Exclusion
- Concomitant severe liver function, renal failure, or other severe system dysfunction
- Poor compliance, inability to obtain information, or voluntary refusal to participate in this study.
Key Trial Info
Start Date :
November 20 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 14 2022
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06092658
Start Date
November 20 2012
End Date
July 14 2022
Last Update
October 23 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.